4//SEC Filing
Epizyme, Inc. 4
Accession 0001209191-14-057964
CIK 0001571498operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 6:26 PM ET
Size
9.0 KB
Accession
0001209191-14-057964
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Hedrick Eric
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-09-15−2,000→ 278,500 totalExercise: $2.19Exp: 2022-06-06→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2014-09-15$2.19/sh+2,000$4,380→ 2,429 total - Sale
Common Stock, par value $0.0001 per share
2014-09-15$28.67/sh−2,000$57,340→ 429 total
Footnotes (3)
- [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Includes 429 shares acquired under the Epizyme, Inc. 2013 Employee Stock Purchase Plan on August 29, 2014.
- [F3]This option was granted on June 7, 2012 with respect to 300,000 shares of Common Stock, with 25% vesting on May 8, 2013 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001571498
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 6:26 PM ET
- Size
- 9.0 KB